Italian drug-discovery firm Axxam is providing the National Institutes of Health's Chemical Genomics Center with a selection of cell lines and cell-based assay protocols for use in the NCGC's high-throughput screening program, Axxam said this week.

Though the agreement lacks any direct financial benefit for Axxam, it could represent an entry point for the company into the US academic and research institute market because the NCGC is the "hub" for the Molecular Library Screening Centers consortium under the NIH's Roadmap for Biomedical Research plan.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Reuters reports that UK researchers are using gene-editing tools to develop flu-resistant chickens.

Nature calls for genomics to become part of the World Health Organization's cholera surveillance approach.

Vox explores a proposal to institute a lottery system to award grant funds.

In Genome Biology this week: gut microbiome study of individuals from Tanzania and Botswana, sixth version of the Network of Cancer Genes database, and more.